Table 3B.
Multivariate analysis of clinical parameters regarding progression-free survival (PFS) of esophageal SCC in elderly patients after definitive or neoadjuvant CRT/RT.
| Factors | HR | CI 95% | p-value |
|---|---|---|---|
| Age | 0.998 | 0.960 - 1.037 | 0.913 |
| ECOG score | 1.475 | 0.897 - 2.425 | 0.125 |
| Administration of full-dose RT | 0.832 | 0.386 - 1.793 | 0.639 |
| Administration of non-modified, full-dose chemotherapy | 0.548 | 0.361 - 0.831 | 0.005 |
| Neoadjuvant CRT followed by surgery vs. definitive RT/CRT | 0.597 | 0.362 - 0.983 | 0.043 |
SCC, squamous cell carcinoma; CRT, chemoradiotherapy; RT, radiotherapy; ECOG, Eastern Cooperative Oncology Group. Bold values, significant p-values.